购物车
您的购物车当前为空
SGC-BRDVIII-NC (Compound 35) 是SMARCA2/4和PB1溴结构域(BRD)抑制剂的阴性对照物。通过酚羟基的甲基化,SGC-BRDVIII-NC 完全消除了蛋白质-配体的结合能力,并用于脂肪生成研究。

SGC-BRDVIII-NC (Compound 35) 是SMARCA2/4和PB1溴结构域(BRD)抑制剂的阴性对照物。通过酚羟基的甲基化,SGC-BRDVIII-NC 完全消除了蛋白质-配体的结合能力,并用于脂肪生成研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
| 产品描述 | SGC-BRDVIII-NC (Compound 35) serves as a negative control for the SMARCA2/4 and PB1 bromodomain (BRD) inhibitors. The binding ability of the protein-ligand is completely eliminated in SGC-BRDVIII-NC through the methylation of the phenolic hydroxyl group. This compound is applicable for research in adipogenesis. |
| 分子量 | 385.46 |
| 分子式 | C20H27N5O3 |
| CAS No. | 2650530-02-0 |
| Smiles | O=C(OC(C)(C)C)N1CCN(C=2C=C(N=NC2N)C3=CC=CC=C3OC)CC1 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多